Hikma Pharmaceuticals PLC (OTCMKTS:HKMPY – Get Free Report) was the recipient of a large increase in short interest in the month of December. As of December 15th, there was short interest totaling 2,069 shares, an increase of 93.4% from the November 30th total of 1,070 shares. Based on an average daily volume of 32,075 shares, the short-interest ratio is currently 0.1 days. Based on an average daily volume of 32,075 shares, the short-interest ratio is currently 0.1 days.
Hikma Pharmaceuticals Trading Up 1.0%
OTCMKTS:HKMPY traded up $0.39 during mid-day trading on Friday, hitting $41.45. The company had a trading volume of 1,060 shares, compared to its average volume of 2,882. The business has a fifty day simple moving average of $43.07 and a 200-day simple moving average of $48.03. Hikma Pharmaceuticals has a 1 year low of $39.93 and a 1 year high of $59.26.
About Hikma Pharmaceuticals
Hikma Pharmaceuticals is a multinational pharmaceutical company founded in Amman, Jordan, in 1978. Headquartered in London, the company develops, manufactures and markets a broad range of branded and non-branded generic medicines, as well as speciality injectable products. Over four decades, Hikma has grown from a regional pharmaceutical supplier to a global healthcare provider, maintaining a focus on quality manufacturing and regulatory compliance.
The company operates across three core business segments: branded generics, speciality injectables and non-branded generics.
Read More
- Five stocks we like better than Hikma Pharmaceuticals
- Do not delete, read immediately
- How the Rich Retire
- INVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting Off
- Can Any Expenses Be Deducted From Capital Gains Tax?
- Do you know what Amazon is planning for January 1?
Receive News & Ratings for Hikma Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hikma Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
